Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials.

Autor: Fokas E; Department of Radiotherapy and Oncology, University of Frankfurt, Germany; German Cancer Consortium (DKTK), Partner Site: Frankfurt, Germany; German Cancer Research Center (DKFZ), Partner Site: Frankfurt, Heidelberg, Germany; Frankfurt Cancer Institute, Frankfurt, Germany; Department of Radiation Oncology, Cyberknife and Radiotherapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine Cologne, University Hospital Cologne, Cologne, Germany. Electronic address: emmanouil.fokas@uk-koeln.de., Williams H; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Diefenhardt M; Department of Radiotherapy and Oncology, University of Frankfurt, Germany; German Cancer Consortium (DKTK), Partner Site: Frankfurt, Germany; German Cancer Research Center (DKFZ), Partner Site: Frankfurt, Heidelberg, Germany; Frankfurt Cancer Institute, Frankfurt, Germany., Lin S; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Qin LX; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Piso P; Department of General and Visceral Surgery, Barmherzige Brüder Hospital, 93049 Regensburg, Germany., Dapper H; Department of Radiation Oncology, Cyberknife and Radiotherapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine Cologne, University Hospital Cologne, Cologne, Germany., Germer CT; Department of General and Visceral Surgery, University of Würzburg, Germany., Grützmann R; Department of General and Visceral Surgery, University of Erlangen-Nürnberg, Germany., Tim Friede J; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany., Joshua Smith J; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Saltz LB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wu AJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Weiser MR; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Omer D; Surgery Residency Program, Hackensack Meridian School of Medicine, Hackensack, NJ, USA., Ghadimi M; Department of General and Visceral Surgery, University Medical Center Göttingen, Germany., Hofheinz RD; Department of Medical Oncology, University Hospital Mannheim, Germany., Garcia-Aguilar J; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rödel C; Department of Radiotherapy and Oncology, University of Frankfurt, Germany; German Cancer Consortium (DKTK), Partner Site: Frankfurt, Germany; German Cancer Research Center (DKFZ), Partner Site: Frankfurt, Heidelberg, Germany; Frankfurt Cancer Institute, Frankfurt, Germany.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Oct; Vol. 210, pp. 114291. Date of Electronic Publication: 2024 Aug 22.

Advances in molecular targeted therapies to increase efficacy of (chemo)radiation therapy.

Autor: Viktorsson K; Department of Oncology/Pathology, Karolinska Institutet, Visionsgatan 4, 17164, Solna, Sweden., Rieckmann T; Department of Radiation Oncology, University Medical Center Hamburg Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.; Department of Otolaryngology, University Medical Center Hamburg Eppendorf, Martinistraße 52, 20246, Hamburg, Germany., Fleischmann M; Department of Radiotherapy and Oncology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), University of Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany., Diefenhardt M; Department of Radiotherapy and Oncology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), University of Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany., Hehlgans S; Department of Radiotherapy and Oncology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany., Rödel F; Department of Radiotherapy and Oncology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. franz.roedel@kgu.de.; Frankfurt Cancer Institute (FCI), University of Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany. franz.roedel@kgu.de.; German Cancer Consortium (DKTK) partner site: Frankfurt, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. franz.roedel@kgu.de.

Publikováno v: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2023 Dec; Vol. 199 (12), pp. 1091-1109. Date of Electronic Publication: 2023 Apr 11.

Customized 3D-printed molds for high dose-rate brachytherapy in facial skin cancer: First clinical experience.

Autor: Chatzikonstantinou G; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt am Main, Frankfurt am Main, Germany., Diefenhardt M; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.; Frankfurt Cancer Institute, Frankfurt am Main, Germany., Fleischmann M; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt am Main, Frankfurt am Main, Germany., Meissner M; Department of Dermatology, Venereology and Allergology, University Hospital, Goethe University Frankfurt am Main, Frankfurt am Main, Germany., Scherf C; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt am Main, Frankfurt am Main, Germany., Trommel M; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt am Main, Frankfurt am Main, Germany., Ramm U; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt am Main, Frankfurt am Main, Germany., Rödel C; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.; Frankfurt Cancer Institute, Frankfurt am Main, Germany.; German Cancer Research Center (DKFZ), Heidelberg, German Cancer Consortium (DKTK), Partner Site Frankfurt am Main, Frankfurt am Main, Germany., Tselis N; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt am Main, Frankfurt am Main, Germany., Licher J; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.

Publikováno v: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG [J Dtsch Dermatol Ges] 2023 Jan; Vol. 21 (1), pp. 35-41. Date of Electronic Publication: 2023 Jan 19.

Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trials.

Autor: Diefenhardt M; Department of Radiotherapy and Oncology, University of Frankfurt, 60596 Frankfurt am Main, Germany; Frankfurt Cancer Institute, 60596 Frankfurt am Main, Germany. Electronic address: Markus.Diefenhardt@kgu.de., Fleischmann M; Department of Radiotherapy and Oncology, University of Frankfurt, 60596 Frankfurt am Main, Germany., Martin D; Department of Radiotherapy and Oncology, University of Frankfurt, 60596 Frankfurt am Main, Germany; German Cancer Research Center (DKFZ), Heidelberg, German Cancer Consortium (DKTK), Partner Site Frankfurt am Main, 60596 Frankfurt am Main, Germany., Hofheinz RD; Department of Medical Oncology, University Hospital Mannheim, 68135 Mannheim, Germany., Piso P; Department of General and Visceral Surgery, Hospital Barmherzige Brüder Regensburg, 93049 Regensburg, Germany., Germer CT; Department of General and Visceral Surgery, University of Würzburg, 97080 Würzburg, Germany., Hambsch P; Department of Radiation Therapy, University of Leipzig, 04103 Leipzig, Germany., Grützmann R; Department of General and Visceral Surgery, University of Erlangen-Nürnberg, 91054 Erlangen, Germany., Kirste S; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, 79098 Freiburg, Germany., Schlenska-Lange A; Department of Hematology and Medical Oncology, Hospital Barmherzige Brüder Regensburg, 93049 Regensburg, Germany., Ghadimi M; Department of General, Visceral and Pediatric Surgery, University Medical Center, 37075 Göttingen, Germany., Rödel C; Department of Radiotherapy and Oncology, University of Frankfurt, 60596 Frankfurt am Main, Germany; German Cancer Research Center (DKFZ), Heidelberg, German Cancer Consortium (DKTK), Partner Site Frankfurt am Main, 60596 Frankfurt am Main, Germany; Frankfurt Cancer Institute, 60596 Frankfurt am Main, Germany., Fokas E; Department of Radiotherapy and Oncology, University of Frankfurt, 60596 Frankfurt am Main, Germany; German Cancer Research Center (DKFZ), Heidelberg, German Cancer Consortium (DKTK), Partner Site Frankfurt am Main, 60596 Frankfurt am Main, Germany; Frankfurt Cancer Institute, 60596 Frankfurt am Main, Germany.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Feb; Vol. 179, pp. 109455. Date of Electronic Publication: 2022 Dec 23.